Oxycodonhydrochlorid Hennig (Oxycodone Hydrochloride)

Oxycodone Hydrochloride is used in the management of pain across several clinical pathways:

• Acute postoperative pain: Provides rapid relief of pain following surgical procedures.
• Cancer‑related pain: Helps control persistent pain associated with malignant disease.
• Chronic non‑cancer pain: Reduces pain intensity in conditions such as severe osteoarthritis when other treatments have failed.

• Oxycodone Hydrochloride acts as a full agonist at the µ‑opioid receptors in the central nervous system. Binding to these G‑protein‑coupled receptors inhibits adenylate cyclase activity, reduces neuronal excitability, and decreases the transmission of nociceptive signals, producing analgesia.

Adverse reactions may occur with opioid therapy and should be monitored:

Common Side Effects

• Constipation: reduced gastrointestinal motility.
• Nausea: mild to moderate upset stomach.
• Drowsiness: increased sedation.
• Dry mouth: decreased salivary flow.
• Dizziness: light‑headed sensation.
• Pruritus: mild skin itching.

Serious or Rare Side Effects

• Respiratory depression: slowed breathing that can be life‑threatening.
• Severe hypotension: marked drop in blood pressure.
• Opioid use disorder: risk of dependence and addiction.
• Adrenal insufficiency: impaired stress response.
• Anaphylaxis: rare severe allergic reaction.
• QT prolongation: potential cardiac rhythm disturbance.

When prescribing Oxycodone Hydrochloride, clinicians should consider several safety measures:

• Assess pain severity: confirm that opioid therapy is appropriate.
• Evaluate patient history: screen for prior substance misuse or respiratory disorders.
• Monitor for sedation: watch for excessive drowsiness or impaired cognition.
• Adjust dose cautiously: titrate based on response and tolerability.
• Educate on constipation: advise prophylactic laxatives and hydration.
• Store at below 25°C: keep in the original packaging, protect from moisture and heat.

Oxycodone Hydrochloride can interact with other medicines, requiring careful management:

Major Interactions (Avoid)

• Benzodiazepines: combined CNS depression increases risk of respiratory failure.
• CNS depressants: additive sedation and hypotension.
• MAO inhibitors: may precipitate severe hypertension or serotonin syndrome.

Moderate Interactions (Monitor Closely)

• CYP3A4 inhibitors (e.g., ketoconazole): increase oxycodone plasma levels.
• CYP3A4 inducers (e.g., rifampicin): reduce oxycodone effectiveness.
• Anticholinergics: may worsen constipation.
• Serotonergic agents: potential for serotonin syndrome.
• Alcohol: enhances sedative effects and respiratory depression.